The nation is seeing a growing interest in copyright substances , particularly N,N-Dimethyltryptamine and this lesser-known cannabinoid. Researchers are steadily exploring the potential of these compounds for mental health purposes, prompting a evolving discussion around their regulatory status and responsible use . Although limitations remain, the